List of bibliographic references indexed by new
Number of relevant bibliographic references: 46.
[0-20] [
0 - 20][
0 - 46][
20-40]
| Ident. | Authors (with country if any) | Title |
|---|
| 000147 (2021) |
Anthony Touafchia [France] ; Haleh Bagheri [France] ; Didier Carrié [France] ; Geneviève Durrieu [France] ; Agnès Sommet [France] ; Laurent Chouchana [France] ; François Montastruc [France] | Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns. |
| 000187 (2021) |
Takahisa Mikami [États-Unis] ; Hirotaka Miyashita [États-Unis] ; Takayuki Yamada [États-Unis] ; Matthew Harrington [États-Unis] ; Daniel Steinberg [États-Unis] ; Andrew Dunn [États-Unis] ; Evan Siau [États-Unis] | Risk Factors for Mortality in Patients with COVID-19 in New York City. |
| 000216 (2021) |
Eamon Duffy [Nouvelle-Zélande] ; Nicola Arroll [Nouvelle-Zélande] ; Richard Beasley [Nouvelle-Zélande] ; Thomas Hills [Nouvelle-Zélande] | Regulatory Action to Protect Access to Hydroxychloroquine for Approved Rheumatic Indications During COVID-19 in New Zealand. |
| 000303 (2021) |
Jun Chen [République populaire de Chine] ; Hongzhou Lu [République populaire de Chine] | New challenges to fighting COVID-19: Virus variants, potential vaccines, and development of antivirals. |
| 000304 (2021) |
Sandra Elizabeth Barbosa Da Silva ; José Arion Da Silva Moura ; Tiago Rafael De Sousa Nunes ; Ivan Da Rocha Pitta ; Marina Galdino Da Rocha Pitta | New Trends On Biological Activities And Clinical Studies Of Quinolinic Analogues: A Review. |
| 000345 (2021) |
Claudia Musial [Pologne] ; Magdalena Gorska-Ponikowska [Pologne] | Medical progress: Stem cells as a new therapeutic strategy for COVID-19. |
| 000496 (2021) |
Eun Ji Kim [États-Unis] ; Kevin Coppa [États-Unis] ; Jamie S. Hirsch [États-Unis] ; Sara Abrahams [États-Unis] ; Jennifer Johnson [États-Unis] ; Martin Lesser [États-Unis] ; Karina W. Davidson [États-Unis] ; Joseph Conigliaro [États-Unis] | Examination of patient characteristics and hydroxychloroquine use based on the US Food and Drug Administration's recommendation: a cross-sectional analysis in New York. |
| 000565 (2021) |
Iwein Gyselinck [Belgique] ; Laurens Liesenborghs [Belgique] ; Ewout Landeloos [Belgique] ; Ann Belmans [Belgique] ; Geert Verbeke [Belgique] ; Peter Verhamme [Belgique] ; Robin Vos [Belgique] ; W. Janssens [Belgique] | Direct antivirals working against the novel coronavirus: azithromycin (DAWn-AZITHRO), a randomized, multicenter, open-label, adaptive, proof-of-concept clinical trial of new antivirals working against SARS-CoV-2-azithromycin trial. |
| 000806 (2020) |
Giuseppe Magro [Italie] | SARS-CoV-2 and COVID-19: What are our options? Where should we focus our attention on to find new drugs and strategies? |
| 000920 (2020) |
Áurea Redondo-Sendino [Espagne] ; Isabel Cristina González Sánchez [Espagne] ; Beatriz De Victoria Fernández [Espagne] | [Skin manifestations associated with the new coronavirus SARS-CoV-2 disease]. |
| 000A01 (2020) |
Yibin Wang [États-Unis] ; Roger Foo [Singapour] ; Thomas Thum [Allemagne] | Using "old" medications to fight new COVID-19: Re-purposing with a purpose. |
| 000B98 (2020) |
Jacques Fantini [France] ; Coralie Di Scala [France] ; Henri Chahinian [France] ; Nouara Yahi [France] | Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. |
| 000C52 (2020) |
Michele Costanzo [Italie] ; Maria Anna Rachele De Giglio [Italie] ; Giovanni Nicola Roviello [Italie] | SARS-CoV-2: Recent Reports on Antiviral Therapies Based on Lopinavir/Ritonavir, Darunavir/Umifenovir, Hydroxychloroquine, Remdesivir, Favipiravir and other Drugs for the Treatment of the New Coronavirus. |
| 000D56 (2020) |
Enrique Asensio [Mexique] ; Rafael Acunzo [Argentine] ; William Uribe [Colombie] ; Eduardo B. Saad [Brésil] ; Luis C. Sáenz [Colombie] | Recommendations for the measurement of the QT interval during the use of drugs for COVID-19 infection treatment. Updatable in accordance with the availability of new evidence. |
| 000E95 (2020) |
Sapna A. Mehta [États-Unis] ; Jeanette Leonard [États-Unis] ; Pauline Labella [États-Unis] ; Katarzyna Cartiera [États-Unis] ; Irfana Soomro [États-Unis] ; Henry Neumann [États-Unis] ; Robert A. Montgomery [États-Unis] ; Nicole M. Ali [États-Unis] | Outpatient management of kidney transplant recipients with suspected COVID-19-Single-center experience during the New York City surge. |
| 000F31 (2020) |
Christian A. Devaux [France] ; Jean-Marc Rolain [France] ; Philippe Colson [France] ; Didier Raoult [France] | New insights on the antiviral effects of chloroquine against coronavirus: what to expect for COVID-19? |
| 000F32 (2020) |
Yuan Hou [États-Unis] ; Junfei Zhao [États-Unis] ; William Martin [États-Unis] ; Asha Kallianpur [États-Unis] ; Mina K. Chung [États-Unis] ; Lara Jehi [États-Unis] ; Nima Sharifi [États-Unis] ; Serpil Erzurum [États-Unis] ; Charis Eng [États-Unis] ; Feixiong Cheng [États-Unis] | New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis. |
| 000F33 (2020) |
Davide Gentile [Italie] ; Virginia Fuochi [Italie] ; Antonio Rescifina [Italie] ; Pio Maria Furneri [Italie] | New Anti SARS-Cov-2 Targets for Quinoline Derivatives Chloroquine and Hydroxychloroquine. |
| 000F69 (2020) |
Carol A. Mancuso [États-Unis] ; Roland Duculan [États-Unis] ; Deanna Jannat-Khah [États-Unis] ; Medha Barbhaiya [États-Unis] ; Anne R. Bass [États-Unis] ; Lisa A. Mandl [États-Unis] ; Bella Mehta [États-Unis] | Modifications in Systemic Rheumatic Disease Medications: Patients' Perspectives during the Height of the COVID-19 Pandemic in New York City. |
| 000F72 (2020) |
Andrew Hill [Royaume-Uni] ; Junzheng Wang [Royaume-Uni] ; Jacob Levi [Royaume-Uni] ; Katie Heath [Australie] ; Joseph Fortunak [États-Unis] | Minimum costs to manufacture new treatments for COVID-19. |
| 000F78 (2020) |
Arash Dabestani [États-Unis] ; Dawn Deangelo [États-Unis] ; Sophia R. Chhay [États-Unis] ; Bayli J. Larson [États-Unis] ; Michael C. Ganio [États-Unis] | Medication utilization in patients in New York hospitals during the COVID-19 pandemic. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "new"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i \
-Sk "new" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidChloroV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= Title.i
|clé= new
}}
| This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021 |  |
